Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland

Oncogene

Volumn 25, Issue 55, 2006, Pages 7245-7259

  Smith, A P L ^a,e   Henze, M ^a   Lee, J A ^b   Osborn, K G ^a   Keck, J M ^a   Tedesco, D ^a   Bortner, D M ^c   Rosenberg, M P ^c   Reed, S I ^a,d  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

^d Department of Molecular Biology ^*  (United States)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Cyclin E; Genomic instability; Loss of heterozygosity; Mammary tumorigenesis; p53

Indexed keywords

CYCLIN E; PROTEIN P53;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC SUSCEPTIBILITY; GENOMIC INSTABILITY; HETEROZYGOSITY; HETEROZYGOSITY LOSS; LACTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN E; GENES, P53; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 33751329698     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209713     Document Type: Article

References (56)

1. Barnes DM, Gillett CE. (1998). Breast Cancer Res Treat 52: 1-15.
2. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. (2005). Nature 434: 864-870.
3. Bieche I, Olivi M, Nogues C, Vidaud M, Lidereau R. (2002). Br J Cancer 86: 580-586.
4. Blagosklonny MV, Pardee AB. (2002). Cell Cycle 1: 103-110.
5. Bortner DM, Rosenberg MP. (1997). Mol Cell Biol 17: 453-459.
6. Calhoun ES, Jones JB, Ashfaq R, Adsay V, Baker SJ, Valentine V et al. (2003). Am J Pathol 163: 1255-1260.
7. Clarke AR, Maandag ER, van Roon M, van der Lugt NM, van der Valk M, Hooper ML et al. (1992). Nature 359: 328-330.
8. Clurman BE, Sheaff RJ, Thress K, Groudine M, Roberts JM. (1996). Genes Dev 10: 1979-1990.
9. Covini G, Chan EK, Nishioka M, Morshed SA, Reed SI, Tan EM. (1997). Hepatology 25: 75-80.
10. Cui XS, Donehower LA. (2000). Oncogene 19: 5988-5996.
11. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS et al. (1992). Nature 356: 215-221.
12. Ekholm-Reed S, Mendez J, Tedesco D, Zetterberg A, Stillman B, Reed SI. (2004a). J Cell Biol 165: 789-800.
13. Ekholm-Reed S, Spruck CH, Sangfelt O, van Drogen F, Mueller-Holzner E, Widschwendter M et al. (2004b). Cancer Res 64: 795-800.
14. Geisen C, Karsunky H, Yucel R, Moroy T. (2003). Oncogene 22: 1724-1729.
15. Geisen C, Moroy T. (2002). J Biol Chem 277: 39909-39918.
16. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T et al. (2005). Nature 434: 907-913.
17. Hamilton AS, Mack TM. (2003). N Engl J Med 348: 2313-2322.
18. Hosokawa Y, Papanikolaou A, Cardiff RD, Yoshimoto K, Bernstein M, Wang TC et al. (2001). Transgenic Res 10: 471-478.
19. Hubalek MM, Widschwendter A, Erdel M, Gschwendtner A, Fiegl HM, Muller HM et al. (2004). Oncogene 23: 4187-4192.
20. Innocente SA, Abrahamson JL, Cogswell JP, Lee JM. (1999). Proc Natl Acad Sci USA 96: 2147-2152.
21. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. (1992). Nature 359: 295-300.
22. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT et al. (1994). Curr Biol 4: 1-7.
23. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. (2001). Nat Genet 29: 418-425.
24. Karsunky H, Geisen C, Schmidt T, Haas K, Zevnik B, Gau E et al. (1999). Oncogene 18: 7816-7824.
25. Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T et al. (2004). Cancer Res 64: 4800-4809.
26. Krause K, Wasner M, Reinhard W, Haugwitz U, Dohna CL, Mossner J et al. (2000). Nucl Acids Res 28: 4410-4418.
27. Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. (2002). Nat Genet 32: 355-357.
28. Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K et al. (1992). Nature 359: 288-294.
29. Lindahl T, Landberg G, Ahlgren J, Nordgren H, Norberg T, Klaar S et al. (2004). Carcinogenesis 25: 375-380.
30. Loeb KR, Kostner H, Firpo E, Norwood T, Tsuchiya K, Clurman BE et al. (2005). Cancer Cell 8: 35-47.
31. Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K et al. (1997). Genes Dev 11: 1479-1492.
32. Malumbres M, Barbacid M. (2001). Nat Rev Cancer 1: 222-231.
33. Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK. (2001). Nature 413: 311-316.
34. Moon RC. (1969). Int J Cancer 4: 312-317.
35. Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA et al. (2000). Oncogene 19: 1635-1646.
36. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. (1995). Mol Cell Biol 15: 2612-2624.
37. Park M, Chae HD, Yun J, Jung M, Kim YS, Kim SH et al. (2000). Cancer Res 60: 542-545.
38. Qiu J, Gunaratne P, Peterson LE, Khurana D, Walsham N, Loulseged H et al. (2003). Leukemia 17: 1891-1900.
39. Rajagopalan H, Jallepalli PV, Rago C, Velculescu VE, Kinzler KW, Vogelstein B et al. (2004). Nature 428: 77-81.
40. Resnitzky D, Gossen M, Bujard H, Reed SI. (1994). Mol Cell Biol 14: 1669-1679.
41. Seghezzi W, Chua K, Shanahan F, Gozani O, Reed R, Lees E. (1998). Mol Cell Biol 18: 4526-4536.
42. Simin K, Wu H, Lu L, Pinkel D, Albertson D, Cardiff RD et al. (2004). PLoS Biol 2: 194-205.
43. Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW et al. (2001). Mol Cell 7: 639-650.
44. Spruck CH, Strohmaier H, Sangfelt O, Muller HM, Hubalek M, Muller-Holzner E et al. (2002). Cancer Res 62: 4535-4539.
45. Spruck CH, Won KA, Reed SI. (1999). Nature 401: 297-300.
46. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI. (2001). Nature 413: 316-322.
47. Swanson SM, Guzman RC, Collins G, Tafoya P, Thordarson G, Talamantes F et al. (1995). Cancer Lett 90: 171-181.
48. Thordarson G, Jin E, Guzman RC, Swanson SM, Nandi S, Talamantes F. (1995). Carcinogenesis 16: 2847-2853.
49. Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D et al. (1998). EMBO J 17: 4657-4667.
50. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. (1994). Nature 369: 669-671.
51. Wei Y, Jin J, Harper JW. (2003). Mol Cell Biol 23: 3669-3680.
52. Welcker M, Singer J, Loeb KR, Grim J, Bloecher A, Gurien-West M et al. (2003). Mol Cell 12: 381-392.
53. Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, Goodell MA. (2002). Dev Biol 245: 42-56.
54. Won KA, Reed SI. (1996). EMBO J 15: 4182-4193.
55. Yin XY, Grove L, Datta NS, Katula K, Long MW, Prochownik EV. (2001). Cancer Res 61: 6487-6493.
56. Yu M, Zhan Q, Finn OJ. (2002). Mol Immunol 38: 981-987.